MetaVia names Sarah Browne chief medical officer
MetaVia named Sarah Browne as chief medical officer, effective Oct. 12, 2026. She was a clinical development consultant at Soufflé Therapeutics, advising on development planning and regulatory strategy. Browne previously led clinical development at Altimmune, advancing pemvidutide through Phase 2 and setting Phase 3 st